Hypertension Trial, Recruiting NCT05236348 Sponsor: Aktiia SA Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05236348
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 21 and 85 years old
  • People who can read and speak French
  • People who are able to do simple physical exercises
  • People who are available and willing to attend all 9 study visits
  • People who have signed the trial's consent form

Who may not be able to join:

  • Clinical staff who are working with the lead researcher on this study
  • People whose resting heart rate is faster than 120 beats per minute
  • People who have a heart condition called atrial fibrillation (an irregular heartbeat)
  • People who have diabetes
  • People who have kidney problems
  • People who have an overactive or underactive thyroid gland
  • People who have a rare adrenal gland tumour called pheochromocytoma
  • People who have Raynaud's disease (a condition affecting blood flow to the fingers and toes)
  • People who experience trembling or shivering
  • People where blood pressure readings differ significantly between the two arms — more than 15 mmHg for the upper number or more than 10 mmHg for the lower number (confirm with trial site)
  • People who have paralysis in either arm
  • Women who are known to be pregnant (for one part of the trial only — confirm with trial site)
  • People who have an arteriovenous fistula (a connection between an artery and vein, often created for dialysis)
  • People who have had an arm amputation
  • People whose upper arm measurement is smaller than 22 cm or larger than 42 cm
  • People whose wrist measurement is larger than 21 cm
  • People who have a skin condition that causes the skin to shed or peel
  • People who have lymphoedema (swelling caused by a build-up of fluid in the body's tissues)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gregoire Wuerzner, MD, Service of Nephrology and Hypertension CHUV

Phone: +41797689800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aktiia SA
Registry
ClinicalTrials.gov
Start date
11 January 2022
Est. completion
31 March 2025

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Blood pressure mean value of differences; Blood pressure standard deviation of differences

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov